In this scenario, the panel of Progesterone receptor (PR) & vimentin (both positive in endometrioid carcinoma) with p16, Carcinoembryonic antigen (positive in endocervical carcinoma) is very helpful. The gene discussed is VIM; the disease is endocervical carcinoma.